Nifuroxazide: licence modification. New restrictions in children.
It would be best simply not to use nifuroxazide, an antibacterial agent with no proven specific clinical action. Oral rehydration remains the cornerstone of treatment in this setting.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002662:Child Health Services; D002675:Child, Preschool; D000075202:Contraindications; D003967:Diarrhea / Q000188:drug therapy*; D017277:Drug Approval; D005440:Fluid Therapy; D005602:France; D006801:Humans; D062385:Hydroxybenzoates / Q000627:therapeutic use; D007223:Infant; D009581:Nitrofurans / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D062385:Hydroxybenzoates; D009581:Nitrofurans